first glp-1 approval Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies Translational GLP-1 science continues to

Turn the dose selector at the end of the pen until the window displays the .25 mg mark

Known under brand names Lomaira and Adipex-P, phentermine was the very first oral weight-loss medication approved by the FDA all the way back in 1959

Lancet Diabetes Endocrinol 7(10):776785 Vilsbll T, Christensen M, Junker AE, Knop FK, Gluud LL (2012) Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

However, there was progress in the UK where the government announced Scotland CardioMetabolic Impact Study (SCoMIS) , a pioneering Real-World study, which will provide Wegovy to between 3,000-5,000 people living with Obesity in Scotlands poorest areas free of charge during a three year study [11] Despite FDA phasing out enforcement discretion that allowed GLP-1 compounding during shortages - and setting May 2025 deadlines for compounding to cease - compounding has continued beyond this deadline [12]

This sounds corny, but it gave me hope.

doi: 10.2298/AVB0601003L 75 LobleyG